DPP-4 inhibitors on Blue Shield Rx Enhanced (S2468-004)
Januvia, Tradjenta and the other "gliptins" for type 2 diabetes, checked against this plan's 2026 formulary (its list of covered drugs).
- Plan type
- Stand-alone drug plan (PDP), California
- Premium
- $227.80/month
- Deductible
- None
2 of 5 DPP-4 inhibitors are covered on this plan. None require prior authorization.
3 aren't on the formulary, including sitagliptin and saxagliptin.
- $22.28Tier 3
- $97.38Tier 3
Not on the formulary
sitagliptin, saxagliptin, alogliptin
Patient cost for a 30-day supply at a preferred retail pharmacy. Where the plan charges a percentage (coinsurance), the dollar figure is that share of the plan's negotiated price; "from" means other strengths cost more. Data from the CMS 2026 Part D formulary and pricing files.